Capital Analysts LLC’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.05M Sell
15,171
-849
-5% -$230K 0.11% 168
2025
Q4
$4.02M Sell
16,020
-85
-0.5% -$22.6K 0.11% 156
2025
Q3
$4.62M Sell
16,105
-505
-3% -$135K 0.13% 136
2025
Q2
$4.36M Sell
16,610
-543
-3% -$132K 0.15% 123
2025
Q1
$3.99M Buy
17,153
+301
+2% +$73K 0.15% 125
2024
Q4
$3.87M Sell
16,852
-152
-0.9% -$34.9K 0.16% 114
2024
Q3
$3.8M Buy
17,004
+108
+0.6% +$23.7K 0.15% 118
2024
Q2
$3.44M Buy
16,896
+436
+3% +$88.7K 0.15% 116
2024
Q1
$3.6M Buy
16,460
+48
+0.3% +$10.6K 0.17% 105
2023
Q4
$3.73M Buy
16,412
+837
+5% +$176K 0.19% 100
2023
Q3
$3.13M Sell
15,575
-1,923
-11% -$406K 0.17% 107
2023
Q2
$3.63M Sell
17,498
-190
-1% -$36.9K 0.2% 98
2023
Q1
$3.49M Buy
17,688
+415
+2% +$85.4K 0.2% 102
2022
Q4
$3.49M Buy
17,273
+783
+5% +$153K 0.21% 95
2022
Q3
$2.9M Buy
16,490
+568
+4% +$116K 0.2% 101
2022
Q2
$3.21M Buy
15,922
+96
+0.6% +$20.5K 0.22% 93
2022
Q1
$3.58M Sell
15,826
-603
-4% -$142K 0.23% 93
2021
Q4
$4.43M Sell
16,429
-763
-4% -$189K 0.27% 77
2021
Q3
$4.16M Sell
17,192
-466
-3% -$117K 0.27% 79
2021
Q2
$4.18M Sell
17,658
-332
-2% -$75.6K 0.28% 77
2021
Q1
$3.94M Sell
17,990
-639
-3% -$128K 0.27% 80
2020
Q4
$3.26M Sell
18,629
-83
-0.4% -$14.3K 0.29% 73
2020
Q3
$3.03M Sell
18,712
-578
-3% -$91.6K 0.29% 74
2020
Q2
$2.75M Sell
19,290
-373
-2% -$51.6K 0.29% 80
2020
Q1
$2.13M Sell
19,663
-368
-2% -$53K 0.26% 81
2019
Q4
$2.91M Buy
20,031
+51
+0.3% +$7.36K 0.29% 80
2019
Q3
$2.88M Buy
19,980
+219
+1% +$32K 0.3% 79
2019
Q2
$2.94M Sell
19,761
-150
-0.8% -$20.9K 0.32% 76
2019
Q1
$2.62M Buy
19,911
+626
+3% +$77.1K 0.3% 78
2018
Q4
$2.09M Sell
19,285
-1,524
-7% -$204K 0.28% 78
2018
Q3
$3.1M Sell
20,809
-482
-2% -$73.3K 0.35% 69
2018
Q2
$3.28M Buy
21,291
+206
+1% +$31.1K 0.39% 63
2018
Q1
$2.93M Buy
21,085
+313
+2% +$46K 0.36% 67
2017
Q4
$2.85M Sell
20,772
-40
-0.2% -$5.29K 0.36% 72
2017
Q3
$2.7M Sell
20,812
-580
-3% -$77.4K 0.36% 74
2017
Q2
$2.83M Sell
21,392
-74
-0.3% -$9.06K 0.4% 60
2017
Q1
$2.65M Buy
21,466
+284
+1% +$33.6K 0.42% 63
2016
Q4
$2.34M Sell
21,182
-1,566
-7% -$174K 0.41% 72
2016
Q3
$2.69M Buy
+22,748
New +$2.68M 0.5% 46

Other funds holding LH

Capital Analysts LLC's LH Position: Q1 2026 in Review

Capital Analysts LLC reduced its Labcorp (LH) stake by 5.3% in Q1 2026, selling an estimated $230K and leaving 15,171 shares worth $4.05M. The position accounts for 0.11% of the portfolio, ranked #168.

Capital Analysts LLC first reported a position in LH in Q3 2016 and has held it in 39 quarters since. The position peaked at $4.62M in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Capital Analysts LLC held 15,171 shares of Labcorp worth $4.05M as of Q1 2026.
  • Capital Analysts LLC sold 849 Labcorp shares in Q1 2026, an estimated $230K.
  • Labcorp made up 0.11% of Capital Analysts LLC's portfolio in Q1 2026, its #168 holding.
  • Capital Analysts LLC first reported a position in Labcorp in Q3 2016 and has held it in 39 quarters since.
  • Capital Analysts LLC's Labcorp position peaked at $4.62M in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.